Docusign Declines 23% in 6 Months: Should You Buy the Stock Right Now?

Docusign (DOCU) is recommended as a "buy" despite a 23.1% six-month decline, with recent gains signaling a potential end to its correction phase. This positive outlook is underpinned by strategic partnerships with Microsoft and Salesforce, which are enhancing its Intelligent Agreement Management (IAM) platform to improve workflow integration and competitive positioning. The stock is considered undervalued, trading at 17.44x forward P/E compared to an industry average of 34.09x, and demonstrates strong fundamentals with a 38% Return on Equity, exceeding the industry's 33.4%, alongside promising long-term revenue and EPS growth projections for fiscal 2026 and 2027.

Analysis

Docusign (DOCU) shares have experienced a significant 23.1% decline over the past six months, underperforming the industry's 1.1% growth and the S&P 500's 19.5% rally. However, a recent 1.5% uptick in the last month suggests a potential end to this correction phase. The stock currently trades at an attractive 17.44x forward 12-month P/E, substantially below the industry average of 34.09x, indicating potential undervaluation.

Key to Docusign's future is its enhanced Intelligent Agreement Management (IAM) platform, bolstered by strategic partnerships with Microsoft and Salesforce. These integrations simplify contract processes within widely used enterprise platforms like Microsoft 365 and Salesforce CRM, aiming to improve workflow efficiency, user retention, and competitive positioning. Fundamentally, DOCU demonstrates strong capital returns with a 38% Return on Equity, exceeding the industry's 33.4%.

The company's top and bottom-line outlook appears promising, with Zacks Consensus Estimates projecting fiscal 2026 revenues at $3.2 billion, representing 7.3% year-over-year growth, and fiscal 2027 revenues growing 3.9%. Fiscal 2026 EPS is estimated at $3.69 (3.9% YoY growth), with 9.9% growth anticipated for fiscal 2027. Notably, EPS estimates for both years have seen upward revisions over the past 60 days, without any downward adjustments.

Key Decisions for Investors

• Investors should consider initiating or increasing a long position in Docusign (DOCU) given its current undervaluation relative to industry peers and strong fundamental metrics.
• Monitor the impact of Docusign's strategic partnerships with Microsoft and Salesforce on user retention and competitive advantage, as these integrations are crucial for long-term growth.
• Pay close attention to future earnings reports and management guidance, particularly regarding the realization of projected revenue and EPS growth for fiscal years 2026 and 2027, which are supported by recent upward estimate revisions.